Resveratrol-Encapsulated Mitochondria-Targeting Liposome Enhances Mitochondrial Respiratory Capacity in Myocardial Cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resveratrol-Encapsulated Mitochondria-Targeting Liposome Enhances Mitochondrial Respiratory Capacity in Myocardial Cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 1, Pages 112
Publisher
MDPI AG
Online
2021-12-23
DOI
10.3390/ijms23010112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitochondrial translocation of DJ-1 is mediated by Grp75
- (2020) Ting-Ting Zhou et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats
- (2020) Abeer M. Alanazi et al. Antioxidants
- Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases
- (2020) Rajasekharreddy Pala et al. International Journal of Nanomedicine
- Antioxidant, antiapoptotic, and antifibrotic effects of the combination of liposomal resveratrol and carvedilol against doxorubicin‐induced cardiomyopathy in rats
- (2020) Abeer Alanazi et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Validation of a mitochondrial RNA therapeutic strategy using fibroblasts from a Leigh syndrome patient with a mutation in the mitochondrial ND3 gene
- (2020) Yuma Yamada et al. Scientific Reports
- Bioenergetics Consequences of Mitochondrial Transplantation in Cardiomyocytes
- (2020) Paria Ali Pour et al. Journal of the American Heart Association
- Role of apolipoprotein E in electronegative low-density lipoprotein-induced mitochondrial dysfunction in cardiomyocytes
- (2020) Wei-Yu Chen et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease
- (2020) Chengming Fan et al. Frontiers in Bioengineering and Biotechnology
- Power of mitochondrial drug delivery systems to produce innovative nanomedicines
- (2020) Yuma Yamada et al. ADVANCED DRUG DELIVERY REVIEWS
- Combined administration of lauric acid and glucose improved cancer‐derived cardiac atrophy in a mouse cachexia model
- (2020) Shota Nukaga et al. CANCER SCIENCE
- Mitochondria-targeted antioxidant delivery for precise treatment of myocardial ischemia–reperfusion injurythrough a multistage continuous targeted strategy
- (2019) Ying Cheng et al. Nanomedicine-Nanotechnology Biology and Medicine
- Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats
- (2019) Chang-xiong Zhang et al. JOURNAL OF NANOBIOTECHNOLOGY
- Chemically synthesized Secoisolariciresinol diglucoside (LGM2605) improves mitochondrial function in cardiac myocytes and alleviates septic cardiomyopathy
- (2019) Dimitra Kokkinaki et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Protective effects of higenamine combined with [6]-gingerol against doxorubicin-induced mitochondrial dysfunction and toxicity in H9c2 cells and potential mechanisms
- (2019) Jianxia Wen et al. BIOMEDICINE & PHARMACOTHERAPY
- Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity
- (2019) Lili Zhang et al. International Journal of Nanomedicine
- Recent Strategies in Resveratrol Delivery Systems
- (2019) Noelia D. Machado et al. ChemPlusChem
- A nanocarrier for the mitochondrial delivery of nucleic acids to cardiomyocytes
- (2019) Yuma Yamada et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function
- (2018) Martijn F. Hoes et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiac progenitor cells activated by mitochondrial delivery of resveratrol enhance the survival of a doxorubicin-induced cardiomyopathy mouse model via the mitochondrial activation of a damaged myocardium
- (2018) Jiro Abe et al. JOURNAL OF CONTROLLED RELEASE
- Heart tissue repair and cardioprotection using drug delivery systems
- (2018) Laura Saludas et al. MATURITAS
- An alternative renin isoform is cardioprotective by modulating mitochondrial metabolism
- (2018) Heike Wanka et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Resveratrol: an effective pharmacological agent to prevent inflammation-induced atrial fibrillation?
- (2018) Henry Sutanto et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes
- (2015) Kyle G. Cheung et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A nanocarrier system for the delivery of nucleic acids targeted to a pancreatic beta cell line
- (2014) Yuma Yamada et al. BIOMATERIALS
- Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice
- (2013) Vernon W. Dolinsky et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Myocardial ischemia-reperfusion injury: a neglected therapeutic target
- (2013) Derek J. Hausenloy et al. JOURNAL OF CLINICAL INVESTIGATION
- Bioaccumulation of resveratrol metabolites in myocardial tissue is dose-time dependent and related to cardiac hemodynamics in diabetic rats
- (2013) L. Bresciani et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen species
- (2010) Brian P. Dranka et al. FREE RADICAL BIOLOGY AND MEDICINE
- Targeting the mitochondria to augment myocardial protection
- (2008) D SCHWARTZ et al. CURRENT OPINION IN PHARMACOLOGY
- MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion
- (2007) Yuma Yamada et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started